These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 19551598)

  • 1. Psychopharmacology for neurologists.
    Dubovsky SL; Dubovsky AN
    Semin Neurol; 2009 Jul; 29(3):200-19. PubMed ID: 19551598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacology: a house divided.
    Dean CE
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):1-10. PubMed ID: 20828593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacology and clinical practice.
    Glod CA
    Nurs Clin North Am; 1991 Jun; 26(2):375-99. PubMed ID: 1675462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to the psychopharmacologic care of patients: antidepressants, antipsychotics, anxiolytics, mood stabilizers, and natural remedies.
    Huffman JC; Alpert JE
    Med Clin North Am; 2010 Nov; 94(6):1141-60, x. PubMed ID: 20951275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological complications of psychiatric drugs: clinical features and management.
    Haddad PM; Dursun SM
    Hum Psychopharmacol; 2008 Jan; 23 Suppl 1():15-26. PubMed ID: 18098217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacology: clinical implications of brain neurochemistry.
    Scheffer RE
    Pediatr Clin North Am; 2006 Aug; 53(4):767-75. PubMed ID: 16873004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The chronobiological approach--a way to enhance the efficacy of pharmacotherapy in neurology and psychiatry].
    Arushanian EB
    Eksp Klin Farmakol; 1992; 55(4):67-9. PubMed ID: 1458197
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of observational data to assess the relative efficacy of alternate treatment modes within inpatient psychiatric facilities.
    Switalski R; Bonato R; Zimmermann R; Kachanoff R
    Psychopharmacol Bull; 1977 Jul; 13(3):45-6. PubMed ID: 18760
    [No Abstract]   [Full Text] [Related]  

  • 9. Self-management of psychiatric symptoms using over-the-counter (OTC) psychopharmacology: the S-DTM therapeutic model--Self-diagnosis, self-treatment, self-monitoring.
    Charlton BG
    Med Hypotheses; 2005; 65(5):823-8. PubMed ID: 16111835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international perspective on pediatric psychopharmacology.
    Vitiello B
    Int Rev Psychiatry; 2008 Apr; 20(2):121-6. PubMed ID: 18386201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric treatments in dermatology: an update.
    Sambhi R; Lepping P
    Clin Exp Dermatol; 2010 Mar; 35(2):120-5. PubMed ID: 19874324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurologic indications of psychotropic drugs].
    Barolin GS
    Rev Clin Esp; 1971 Dec; 123(6):563-6. PubMed ID: 5161140
    [No Abstract]   [Full Text] [Related]  

  • 13. [Status of and perspectives on psychiatric genomic medicine].
    Mors NP; Børglum AD
    Ugeskr Laeger; 2005 May; 167(20):2191-3. PubMed ID: 15987082
    [No Abstract]   [Full Text] [Related]  

  • 14. [Psychopharmacotherapy in the 20th century].
    Siepmann M; Kirch W
    Wien Med Wochenschr; 2001; 151(15-17):397-402. PubMed ID: 11603211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to chlorpromazine in psychiatric patients.
    Swett C
    Dis Nerv Syst; 1974 Nov; 35(11):509-11. PubMed ID: 17896459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders.
    Bernardo CG; Singh V; Thompson PM
    Expert Opin Drug Saf; 2008 Jul; 7(4):435-45. PubMed ID: 18613807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.
    Wood MD; Wren PB
    Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should neurologists be trained to recognize and treat comorbid depression of neurologic disorders? Yes.
    Kanner AM
    Epilepsy Behav; 2005 May; 6(3):303-11. PubMed ID: 15820336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pitfalls in psychopharmacological drug use].
    Huttunen MO; Raaska K
    Duodecim; 2015; 131(18):1651-7. PubMed ID: 26591644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of neuropsychiatric syndromes in neurologic disorders: definitional and regulatory aspects.
    Cummings JL; Jeste DV
    Psychopharmacol Bull; 2007; 40(4):89-98. PubMed ID: 18227780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.